557 related articles for article (PubMed ID: 28942246)
21. Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis.
Xiao XH; Wang YD; Qi XY; Wang YY; Li JY; Li H; Zhang PY; Liao HL; Li MH; Liao ZZ; Yang J; Xu CX; Wen GB; Liu JH
Int J Obes (Lond); 2018 Aug; 42(8):1418-1430. PubMed ID: 30006580
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis.
Shu Y; Hassan F; Coppola V; Baskin KK; Han X; Mehta NK; Ostrowski MC; Mehta KD
Mol Metab; 2021 Feb; 44():101133. PubMed ID: 33271332
[TBL] [Abstract][Full Text] [Related]
23. Impaired Ca
Ali ES; Girard D; Petrovsky N
Am J Physiol Cell Physiol; 2021 Jul; 321(1):C187-C198. PubMed ID: 34106786
[TBL] [Abstract][Full Text] [Related]
24. Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance.
Qiao L; Men L; Yu S; Yao J; Li Y; Wang M; Yu Y; Wang N; Ran L; Wu Y; Du J
Cell Death Dis; 2022 Mar; 13(3):275. PubMed ID: 35347118
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
26. Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism.
Miyazaki M; Kato M; Tanaka K; Tanaka M; Kohjima M; Nakamura K; Enjoji M; Nakamuta M; Kotoh K; Takayanagi R
Mol Med Rep; 2012 Mar; 5(3):729-33. PubMed ID: 22179204
[TBL] [Abstract][Full Text] [Related]
27. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease.
Cao X; Song LN; Zhang YC; Li Q; Shi TT; Yang FY; Yuan MX; Xin Z; Yang JK
Diabetes Metab Res Rev; 2019 May; 35(4):e3123. PubMed ID: 30604460
[TBL] [Abstract][Full Text] [Related]
29. Serine prevented high-fat diet-induced oxidative stress by activating AMPK and epigenetically modulating the expression of glutathione synthesis-related genes.
Zhou X; He L; Zuo S; Zhang Y; Wan D; Long C; Huang P; Wu X; Wu C; Liu G; Yin Y
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):488-498. PubMed ID: 29158183
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats.
Pan QR; Ren YL; Liu WX; Hu YJ; Zheng JS; Xu Y; Wang G
Nutr Res; 2015 Jul; 35(7):576-84. PubMed ID: 26055348
[TBL] [Abstract][Full Text] [Related]
31. [The involvement of NOX1/NADPH oxidase in the development of non-alcoholic steatohepatitis].
Matsumoto M
Nihon Yakurigaku Zasshi; 2018; 152(4):181-186. PubMed ID: 30298839
[TBL] [Abstract][Full Text] [Related]
32. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
34. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
[TBL] [Abstract][Full Text] [Related]
35. Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression.
Lee M; Shin E; Bae J; Cho Y; Lee JY; Lee YH; Lee BW; Kang ES; Cha BS
Sci Rep; 2020 Nov; 10(1):19429. PubMed ID: 33173107
[TBL] [Abstract][Full Text] [Related]
36. Caffeic acid ameliorates hepatic steatosis and reduces ER stress in high fat diet-induced obese mice by regulating autophagy.
Kim HM; Kim Y; Lee ES; Huh JH; Chung CH
Nutrition; 2018 Nov; 55-56():63-70. PubMed ID: 29960159
[TBL] [Abstract][Full Text] [Related]
37. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
38. Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice.
Cartland SP; Harith HH; Genner SW; Dang L; Cogger VC; Vellozzi M; Di Bartolo BA; Thomas SR; Adams LA; Kavurma MM
Sci Rep; 2017 May; 7(1):1898. PubMed ID: 28507343
[TBL] [Abstract][Full Text] [Related]
39. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
[TBL] [Abstract][Full Text] [Related]
40. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
